Jul 25, 09:09
Jul 25, 09:08
71% of moneycontrol users recommend buying Dishman Pharma.
What's your call on Dishman Pharma today?
Read 20 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2745.85||1.30||2939.80||2140.35||46,771.45|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dishman Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,216.51 crore.The company has reported a consolidated sales of Rs 400.65 crore and a Net Profit of Rs 22.56 crore for the quarter ended Mar 2014.
The company management includes Janmejay R Vyas - Chairman & Managing Director, Deohooti J Vyas - Whole Time Director, Arpit J Vyas - Whole Time Director, Yagneshkumar B Desai - Director, Sanjay S Majmudar - Director, Ashok C Gandhi - Director.
It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.
Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura. Ahmedabad,Gujarat - 380009.
Their Registrars are Link Intime India Pvt. Ltd.